Literature DB >> 11108136

Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors.

J Lim1, C Yang, S J Hong, K S Kim.   

Abstract

The conversion of L-tyrosine to 3,4-dihydroxy-L-phenylalanine by tyrosine hydroxylase (TH) is the first and rate-limiting step in biosynthesis of catecholamine neurotransmitters. TH gene expression is regulated in a cell type-specific and cAMP-dependent manner. Evidence from this laboratory and others indicates that the cAMP response element (CRE), residing at -45 to -38 bp upstream of the transcription initiation site, is essential for both basal and cAMP-inducible transcription of the TH gene. To understand the control mechanisms of TH gene transcription in greater detail, we sought to identify and characterize the transcription factors involved in recognition and activation of the CRE of the TH gene. Remarkably, electrophoretic mobility shift assay and antibody supershift experiments indicated that all three major CRE-binding protein factors, i.e. CREB, ATF1, and CREM, may participate in forming specific DNA/protein complexes with the CRE of the TH gene. To address the transcriptional activation function of individual factors, we replaced the TH CRE with a GAL4-binding site and cotransfected this modified TH promoter-reporter gene with an effector plasmid that encodes GAL4-fused transcription factor. Our results indicate that CREB but not ATF1 can support basal promoter activity while both can robustly induce the promoter activity in response to co-expression of the catalytic subunit of cAMP-dependent protein kinase (PKA). We further show that the coactivator CBP up-regulates PKA-mediated activation of the TH promoter and, if tethered to the TH promoter by a GAL4-fusion, can robustly transactivate the TH promoter even in the absence of PKA. Collectively, our results suggest that multiple CRE-binding factors interact with the CRE and regulate, in conjunction with the coactivator CBP, the transcriptional activity of the TH gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108136

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription.

Authors:  N S Foulkes; E Borrelli; P Sassone-Corsi
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

2.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

Review 3.  Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation.

Authors:  R E Zigmond; M A Schwarzschild; A R Rittenhouse
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

4.  The homeodomain protein Arix promotes protein kinase A-dependent activation of the dopamine beta-hydroxylase promoter through multiple elements and interaction with the coactivator cAMP-response element-binding protein-binding protein.

Authors:  D J Swanson; M Adachi; E J Lewis
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines.

Authors:  R A Ross; J L Biedler; B A Spengler; D J Reis
Journal:  Cell Mol Neurobiol       Date:  1981-09       Impact factor: 5.046

6.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

7.  Multiple protein factors interact with the cis-regulatory elements of the proximal promoter in a cell-specific manner and regulate transcription of the dopamine beta-hydroxylase gene.

Authors:  H Seo; C Yang; H S Kim; K S Kim
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

8.  Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice.

Authors:  C Suri; B P Fung; A S Tischler; D M Chikaraishi
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

9.  Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP.

Authors:  E J Lewis; C A Harrington; D M Chikaraishi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator.

Authors:  B L Kee; J Arias; M R Montminy
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

View more
  17 in total

1.  Hypoxic pulmonary vasoconstriction, carotid body function and erythropoietin production in adult rats perinatally exposed to hyperoxia.

Authors:  Jesus Prieto-Lloret; Maria Ramirez; Elena Olea; Javier Moral-Sanz; Angel Cogolludo; Javier Castañeda; Sara Yubero; Teresa Agapito; Angela Gomez-Niño; Asuncion Rocher; Ricardo Rigual; Ana Obeso; Francisco Perez-Vizcaino; Constancio González
Journal:  J Physiol       Date:  2015-05-15       Impact factor: 5.182

2.  Norepinephrine upregulates the expression of tyrosine hydroxylase and protects dopaminegic neurons against 6-hydrodopamine toxicity.

Authors:  Meng-Yang Zhu; Muhammad U Raza; Yanqiang Zhan; Yan Fan
Journal:  Neurochem Int       Date:  2019-09-17       Impact factor: 3.921

3.  The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity.

Authors:  Edward Pajarillo; Asha Rizor; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2020-01-30       Impact factor: 5.157

4.  Acute wounding alters the beta2-adrenergic signaling and catecholamine synthetic pathways in keratinocytes.

Authors:  Raja K Sivamani; Biao Shi; Elizabeth Griffiths; Shirley M Vu; Hadar A Lev-Tov; Sara Dahle; Marianne Chigbrow; Thi Dinh La; Chelcy Mashburn; Thomas R Peavy; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2014-03-10       Impact factor: 8.551

Review 5.  Noradrenergic Modulation on Dopaminergic Neurons.

Authors:  Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2018-03-23       Impact factor: 3.911

6.  NMDA receptor glycine modulatory site in the ventral tegmental area regulates the acquisition, retrieval, and reconsolidation of cocaine reward memory.

Authors:  Shuang-jiang Zhou; Li-fen Xue; Xue-yi Wang; Wen-gao Jiang; Yan-xue Xue; Jian-feng Liu; Yin-yin He; Yi-xiao Luo; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2011-11-23       Impact factor: 4.530

7.  Activation of CREB/ATF sites by polyomavirus large T antigen.

Authors:  Tara M Love; Rowena de Jesus; Jennifer A Kean; Qing Sheng; Andrew Leger; Brian Schaffhausen
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 8.  Human embryonic stem cells for brain repair?

Authors:  Su-Chun Zhang; Xue-Jun Li; M Austin Johnson; Matthew T Pankratz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 9.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.

Authors:  Ryan S Friese; Angelina E Altshuler; Kuixing Zhang; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Martin L Jirout; Rany M Salem; Jiaur R Gayen; Nitish R Mahapatra; Nilima Biswas; Mo Cale; Sucheta M Vaingankar; Hyung-Suk Kim; Maïté Courel; Laurent Taupenot; Michael G Ziegler; Nicholas J Schork; Michal Pravenec; Sushil K Mahata; Geert W Schmid-Schönbein; Daniel T O'Connor
Journal:  Hum Mol Genet       Date:  2013-05-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.